Kyogoku unyu shoji
9073
BlueMeme
4069
Estore
4304
Visumo
303A
D. Western Therapeutics Institute
4576
(FY)Mar 31, 2024 | (FY)Mar 31, 2023 | (FY)Mar 31, 2022 | (FY)Mar 31, 2021 | (FY)Mar 31, 2020 | (Q4)Mar 31, 2020 | (Q3)Dec 31, 2019 | (Q2)Sep 30, 2019 | (Q1)Jun 30, 2019 | (FY)Mar 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating cash flow (Indirect Method) | ||||||||||
Cash from operating activities | 159.35%1.79B | -71.28%690.77M | 127.06%2.41B | -40.93%1.06B | -36.99%1.79B | 309.57M | -12.98%703.37M | -47.26%229.56M | -39.45%550.59M | 1.16%2.85B |
Net profit before non-cash adjustment | 55.95%1.51B | 33.79%967.42M | 253.60%723.11M | -254.44%-470.79M | -83.34%304.84M | ---381.73M | -69.26%167.89M | -49.15%233.73M | -39.46%284.96M | -11.07%1.83B |
Total adjustment of non-cash items | -35.89%783.51M | 7.22%1.22B | -26.96%1.14B | 3.89%1.56B | 25.45%1.5B | --808.67M | 31.53%349.9M | -42.07%198.56M | -43.46%145.1M | 98.31%1.2B |
-Depreciation and amortization | -6.21%1.34B | 9.23%1.43B | -0.88%1.3B | 17.20%1.32B | 4.60%1.12B | --265.98M | -5.09%320.12M | 10.87%236.74M | -3.59%300.1M | -7.14%1.07B |
-Reversal of impairment losses recognized in profit and loss | ---- | ---- | ---- | -7.49%190.8M | --206.25M | ---- | ---- | ---- | ---- | ---- |
-Disposal profit | -1,151.35%-467M | 502.56%44.42M | 72.17%-11.03M | -106.29%-39.65M | 548.16%630.3M | --469.67M | 1,138.07%45.72M | 30.28%183.14M | 0.00%-68.24M | 223.96%97.24M |
-Other non-cash items | 65.20%-86.06M | -60.95%-247.28M | -264.56%-153.64M | 120.42%93.36M | -1,811.67%-457.26M | ---133.23M | 78.74%-15.94M | -1,846.90%-221.32M | -738.36%-86.76M | 105.64%26.71M |
Changes in working capital | 66.60%-500.67M | -376.50%-1.5B | 1,871.74%542.06M | -118.47%-30.6M | 92.31%-14M | ---117.38M | 4,854.68%185.58M | 44.78%-202.73M | -33.76%120.53M | -220.36%-182.05M |
-Change in receivables | 180.75%617.25M | -235.62%-764.42M | 60.72%-227.76M | -170.14%-579.87M | 44.36%826.72M | --370.34M | 31.83%257.11M | 200.12%151.41M | -82.13%47.85M | 235.82%572.68M |
-Change in inventory | 119.75%119.84M | -151.20%-606.8M | -138.53%-241.57M | 1,062.60%626.88M | 140.31%53.92M | --41.26M | -523.82%-110.53M | 163.41%56.14M | 4,178.41%67.05M | -51.16%-133.75M |
-Change in payables | -420.90%-1.29B | -124.23%-247.02M | 2,231.04%1.02B | 93.94%-47.84M | -49.58%-789.3M | ---476.73M | 214.10%141.95M | -214.22%-406.41M | 55.14%-48.11M | -168.88%-527.68M |
-Provision for loans, leases and other losses | -59.03%48.94M | 1,566.64%119.44M | 72.63%-8.14M | 71.75%-29.76M | -12.92%-105.34M | ---52.25M | -2.32%-102.95M | 81.99%-4.42M | 9.39%54.28M | 10.90%-93.29M |
-Changes in other current assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 97.93%-548K | ---- |
Dividends paid (cash flow from operating activities) | ||||||||||
Dividends received (cash flow from operating activities) | ||||||||||
Interest paid (cash flow from operating activities) | -3.10%-29.93M | -7.30%-29.03M | 10.16%-27.06M | -156.90%-30.12M | -33.25%-11.72M | -5.12M | -2.00%-2.25M | 0.14%-2.2M | 8.90%-2.16M | 7.11%-8.8M |
Interest received (cash flow from operating activities) | 42.26%259.31M | 44.46%182.27M | 4.39%126.18M | -37.71%120.87M | 14.52%194.05M | 32.28M | -6.02%63.02M | 95.14%30.5M | 0.01%68.25M | -30.07%169.45M |
Tax refund paid | 15.50%-225.79M | -329.57%-267.2M | 43.29%-62.2M | 66.09%-109.68M | 32.26%-323.49M | -1.41M | 33.18%-172.81M | -50.39%-88.23M | 58.30%-61.05M | 22.66%-477.55M |
Other operating cash inflow (outflow) | -41.73M | 0 | 0.00%-1K | 0.00%-1K | 0.00%-1K | -2K | 200.00%1K | 0 | 0 | 100.00%-1K |
Operating cash flow | 203.98%1.75B | -76.38%576.82M | 134.74%2.44B | -37.02%1.04B | -34.67%1.65B | --335.31M | -3.77%591.33M | -56.51%169.63M | -32.95%555.63M | 6.69%2.53B |
Investing cash flow | ||||||||||
Net PPE purchase and sale | 0.92%-1.06B | 3.67%-1.07B | -33.67%-1.11B | 49.04%-833.98M | -78.61%-1.64B | ---507.99M | -159.88%-454.35M | 10.47%-288.57M | -132.67%-385.75M | 28.82%-916.32M |
Net intangibles purchase and sale | 38.53%-26.53M | 0.21%-43.15M | -18.78%-43.24M | ---36.41M | ---- | ---- | ---- | ---- | ---- | ---- |
Net investment product transactions | 1,981.18%608.58M | -86.12%29.24M | -74.77%210.67M | 189,641.36%834.86M | 100.06%440K | --2.19M | 99.94%-149K | 99.71%-1.45M | 97.11%-149K | -228.26%-742.38M |
Net changes in other investments | -293.16%-2.85B | 356.69%1.48B | 87.60%-575.14M | -309,518.69%-4.64B | -124.25%-1.5M | ---1.52M | -75.00%1K | -96.11%19K | -100.22%-1K | -102.24%-668K |
Investing cash flow | -958.09%-3.33B | 125.52%388.5M | 67.42%-1.52B | -185.37%-4.67B | 1.30%-1.64B | ---507.32M | -10.65%-454.5M | 64.72%-290M | -125.07%-385.9M | -137.38%-1.66B |
Financing cash flow | ||||||||||
Net issuance payments of debt | -206.38%-1.2B | 2,147.25%1.13B | 94.86%-55.1M | -120.87%-1.07B | 3,526.67%5.14B | --5B | -20.00%40M | --0 | --100M | -1,300.00%-150M |
Net common stock issuance | 53.13%-15K | ---32K | --0 | ---- | -9,805,970.69%-5.69B | ---5.69B | --0 | --0 | 63.79%-21K | 19.44%-58K |
Increase or decrease of lease financing | ---9.57M | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Cash dividends paid | -1.09%-372.49M | 0.00%-368.49M | -0.27%-368.49M | 25.38%-367.49M | -17.65%-492.49M | --0 | --0 | --0 | -17.65%-492.49M | -21.72%-418.62M |
Cash dividends for minorities | -7.26%-2.97M | ---2.77M | --0 | 1.89%-4.15M | -0.38%-4.23M | --0 | --0 | --0 | -0.38%-4.23M | -6.35%-4.22M |
Net other fund-raising expenses | 0.00%-2K | -100.00%-2K | 50.00%-1K | -100.00%-2K | 0.00%-1K | --0 | --0 | --0 | 0.00%-1K | 0.00%-1K |
Financing cash flow | -309.46%-1.59B | 278.65%756.74M | 70.68%-423.59M | -38.34%-1.44B | -82.28%-1.04B | ---687.5M | -20.03%40M | --0 | 6.18%-396.74M | -70.79%-572.89M |
Net cash flow | ||||||||||
Beginning cash position | 30.14%7.47B | 9.17%5.74B | -50.27%5.26B | -6.80%10.57B | 2.24%11.34B | --11.31B | 4.62%11.11B | -0.54%11.21B | 2.24%11.34B | 15.95%11.09B |
Current changes in cash | -283.81%-3.17B | 247.26%1.72B | 109.77%495.89M | -392.97%-5.08B | -447.59%-1.03B | ---859.5M | -30.32%176.83M | 79.32%-120.37M | -196.86%-227.02M | -77.81%296.34M |
Effect of exchange rate changes | 2,217.29%177.02M | 155.89%7.64M | 94.20%-13.67M | -190.83%-235.59M | 641.43%259.38M | --117.9M | -85.52%23.58M | 135.16%23.58M | 264.07%94.32M | -125.24%-47.91M |
Cash adjustments other than cash changes | ---- | 400.00%3K | 50.00%-1K | ---2K | ---- | ---- | ---- | ---- | ---- | -100.00%-2K |
End cash Position | -40.02%4.48B | 30.14%7.47B | 9.17%5.74B | -50.27%5.26B | -6.80%10.57B | --10.57B | 2.49%11.31B | 4.62%11.11B | -0.54%11.21B | 2.24%11.34B |
Free cash flow | 204.32%662.87M | -149.55%-635.44M | 654.66%1.28B | 1,133.26%169.92M | -99.14%13.78M | ---174.14M | -68.91%136.98M | -275.61%-118.94M | -74.34%169.88M | 51.86%1.61B |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |